Guardant Health
GH
#3260
Rank
C$5.06 B
Marketcap
$40.99
Share price
-3.64%
Change (1 day)
33.29%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2023 (TTM): -$6.65

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -$6.91. In 2022 the company made an earnings per share (EPS) of -$9.01 a decrease over its 2021 EPS that were of -$5.63.

EPS history for Guardant Health from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$6.65-26.18%
2022-$9.0160%
2021-$5.6355.04%
2020-$3.63207.14%
2019-$1.18-19.81%
2018-$1.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$6.79-1.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.17-97.57%๐Ÿ‡บ๐Ÿ‡ธ USA